Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Prospective Study of Rapamycin for the Treatment of SLE (Rapamune)

This study is currently recruiting participants. (see Contacts and Locations)
Verified December 2012 by State University of New York - Upstate Medical University
Sponsor:
Collaborator:
Pfizer
Information provided by:
State University of New York - Upstate Medical University
ClinicalTrials.gov Identifier:
NCT00779194
First received: October 23, 2008
Last updated: December 12, 2012
Last verified: December 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: October 2013 (Final data collection date for primary outcome measure)